Can Near-Infrared Light Treat Depression?
It is promising but not proven. This review found that animal and early human studies suggest transcranial photobiomodulation (t-PBM) with near-infrared light may have significant efficacy and good tolerability in major depressive disorder, and the authors call for large confirmatory trials. If confirmed, it could fill a gap between medications with significant side effects and device-based therapies that require repeated clinic visits.
Red light therapy, also known as low-level laser therapy (LLLT) or photobiomodulation (PBM), uses specific wavelengths of red and near-infrared light to promote healing and reduce inflammation.
Major depressive disorder (MDD) is one of the most common conditions worldwide, associated with high rates of disability and even suicidal behavior. Current treatments have significant limitations. Antidepressant medications often come with side effects including weight gain, sexual dysfunction, and emotional blunting. FDA-approved device therapies like electroconvulsive therapy and transcranial magnetic stimulation require repeated in-office procedures and are most suitable for severely ill patients. There is a clear need for something that is effective, well tolerated, and practical for everyday use.
What the Research Shows
The review examined the biological mechanisms of t-PBM as well as its efficacy in both animal models and human patients. Near-infrared light penetrates the skull and reaches the prefrontal cortex, the brain region most associated with mood regulation. The proposed mechanisms include stimulation of the mitochondrial respiratory chain in brain cells, increased cerebral blood flow, and reduced neuroinflammation. Animal and human studies, using a variety of settings and experimental models, suggest t-PBM may help depression. Few adverse effects were reported, mainly headaches, fatigue and skin warming, though not every trial reported safety data and most followed people only briefly.
Dr. Kumar’s Take
Depression badly needs new options. Current medications help some people, but more than a third of patients do not reach remission after several adequate trials, and side effects drive many to stop. The appeal of t-PBM is that it could potentially be used at home, on a person’s own schedule, without the side effects of drugs or the burden of repeated clinic visits. Near-infrared light can reach the prefrontal cortex, a region involved in depression, and there is a plausible mechanism. But the human studies so far are small and used varied settings, and the authors note that the effectiveness of cheaper LED devices is still in question.
Why the Prefrontal Cortex Matters
In depression, the prefrontal cortex often shows reduced metabolic activity. This brain region is critical for regulating mood, making decisions, and controlling emotional responses. When it is underactive, people experience the flat mood, difficulty concentrating, and loss of motivation that characterize depression. By delivering near-infrared light to the forehead, t-PBM may boost energy production in these neurons. That is the hypothesis; it has not been confirmed in large trials.
Practical Takeaways
- Transcranial photobiomodulation with near-infrared light shows early promise for major depressive disorder, pending large confirmatory trials.
- Few side effects have been reported so far, though safety data are short term.
- t-PBM can potentially be used at home, making it more practical than clinic-based device therapies.
- This is a supplemental approach and should not replace existing treatment without medical guidance.
FAQs
How does t-PBM compare to antidepressant medications?
t-PBM works through a different proposed mechanism than medications, targeting energy production in brain cells rather than altering neurotransmitter levels chemically. It has not been compared head to head with antidepressants in large trials, so there is no good answer yet.
Can I use t-PBM alongside my current depression treatment?
Discuss that with your mental health provider first. t-PBM is still experimental, and any change to current treatment should be made with them.
How quickly does t-PBM work for depression?
The studies in this review used a wide range of schedules, often several weeks of repeated sessions, so there is no settled answer on timing yet.
Bottom Line
Transcranial red and near-infrared light therapy is a promising but unproven approach to major depressive disorder. It targets brain energy metabolism and blood flow, has shown few side effects so far, and could potentially be used at home. The authors are clear that large confirmatory trials are needed before it can be considered an established treatment.
